MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 12351-12360 Newer>
BusinessWeek
February 20, 2006
Gene G. Marcial
Medallion Financial Is Cruising Right Along As the No. 1 financier to cabbies in big cities such as Boston, Chicago, and New York, Medallion makes a tidy profit on its 7%-to-9% interest. Is this value stock a buy? mark for My Articles 8 similar articles
BusinessWeek
February 20, 2006
Gene G. Marcial
Fast Growth At Illumina Is In The Genes The company has become a rising star in the complex analysis of gene variation, and the stock shows it. mark for My Articles 115 similar articles
InternetNews
February 9, 2006
Sean Michael Kerner
Vonage Headed to IPO Market The VoIP vendor is looking to fetch $250 million amidst continuing losses. Vonage's SEC filing also provides a glimpse into the business activities of one the leading VoIP services. mark for My Articles 303 similar articles
The Motley Fool
February 9, 2006
Stephen D. Simpson
Serono: On the Block and on the Clock Will the Swiss-based biotech be able to strike a good deal for shareholders? mark for My Articles 194 similar articles
The Motley Fool
February 9, 2006
Stephen D. Simpson
Better Days Ahead for Unilever Though not completely back on track, the company has made significant strides. More aggressive investors might find the potential in these shares a little unimpressive, but it still seems like a solid turnaround story. mark for My Articles 92 similar articles
The Motley Fool
February 9, 2006
Stephen D. Simpson
Mentor Needs Some Prettying Up Until new products are approved or acquired, the aesthetics and urology company seems stuck in suspended animation. Just standing in place is not going to build much shareholder value. mark for My Articles 26 similar articles
The Motley Fool
February 9, 2006
Brian Gorman
Charles River Bets on Preclinical The company is reportedly seeing more activity from biotech outfits, in addition to existing business from larger pharmaceutical names like Eli Lilly and Pfizer. But a large expansion in preclinical capacity warrants close watching. Investors, take note. mark for My Articles 89 similar articles
The Motley Fool
February 9, 2006
Rich Smith
The Olympics and Investing: The Home Team Get to Know a Country: And where better to begin than with Olympic host nation Italy. This is a pretty easy country to get to know, investment-wise: Benetton... De Rigo... Luxottica... Natuzzi ... mark for My Articles 47 similar articles
The Motley Fool
February 9, 2006
Rick Aristotle Munarriz
Love on Sale It's not that easy to find the Valentine's Day plays anymore. But all hope isn't lost. You still have companies like 1-800-Flowers and Rocky Mountain Chocolate Factory to consider. mark for My Articles 93 similar articles
The Motley Fool
February 9, 2006
Rick Aristotle Munarriz
Over My Dead Portfolio's Body An investor needs to know when to sit -- and when to sell. mark for My Articles 136 similar articles
<Older 12351-12360 Newer>    Return to current articles.